Risk factors and complications of intracranial pressure monitoring with a fiberoptic device

Simple item page
dc.contributor.buuauthorBekar, Ahmet
dc.contributor.buuauthorDoğan, Şeref
dc.contributor.buuauthorAbaş, Faruk
dc.contributor.buuauthorCaner, Burcu
dc.contributor.buuauthorKorfalı, Gülşen
dc.contributor.buuauthorKocaeli, Hasan
dc.contributor.buuauthorYılmazlar, Selçuk
dc.contributor.buuauthorKorfalı, Ender
dc.contributor.buuauthorCaner, Burcu
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroşirürji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Anestezi ve Reanimasyon Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-3633-7919tr_TR
dc.contributor.researcheridAAI-6531-2021tr_TR
dc.contributor.researcheridAAH-5070-2021tr_TR
dc.contributor.scopusid7102693077tr_TR
dc.contributor.scopusid6603677218tr_TR
dc.contributor.scopusid8546184300tr_TR
dc.contributor.scopusid25027089000tr_TR
dc.contributor.scopusid6701462594tr_TR
dc.contributor.scopusid6603500567tr_TR
dc.contributor.scopusid6603059483tr_TR
dc.contributor.scopusid7004641343tr_TR
dc.date.accessioned2021-11-15T10:42:44Z
dc.date.available2021-11-15T10:42:44Z
dc.date.issued2009-02
dc.description.abstractWe prospectively investigated the complications associated with intraparenchymal intracranial pressure (ICP) monitoring using the Camino intracranial pressure device. A fiberoptic ICP monitoring transducer was implanted in 631 patients. About half of the patients (n = 303) also received an external ventricular drainage set (EVDS). The durations (mean +/- SD) of ICP monitoring in patients without and with an EVDS were 6.5 +/- 4.4 and 7.3 +/- 5.1 days, respectively. Infection occurred in 6 patients with only an ICP transducer (6/328, 1.8%) and 24 patients with an EVDS also (24/303, 7.9%). The duration of monitoring had no effect on infection, whereas the use of an EVDS for more than 9 days increased infection risk by 5.11 times. Other complications included transducer disconnection (2.37%), epidural hematoma (0.47%), contusion (0.47%), defective probe (0.31%), broken transducer (0.31%), dislocation of the fixation screw (0.15%), and intraparenchymal hematoma (0.15%). In conclusion, intraparenchymal ICP monitoring systems can be safely used in patients who either have, or are at risk of developing, increased ICP.en_US
dc.identifier.citationBekar, A. vd. (2009). "Risk factors and complications of intracranial pressure monitoring with a fiberoptic device". Journal of Clinical Neuroscience, 16(2), 236-240.en_US
dc.identifier.endpage240tr_TR
dc.identifier.issn0967-5868
dc.identifier.issue2tr_TR
dc.identifier.pubmed19071023tr_TR
dc.identifier.scopus2-s2.0-58149182696tr_TR
dc.identifier.startpage236tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.jocn.2008.02.008
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0967586808001082
dc.identifier.urihttp://hdl.handle.net/11452/22653
dc.identifier.volume16tr_TR
dc.identifier.wos000264181900010tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.journalJournal of Clinical Neuroscienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComplicationsen_US
dc.subjectFiberoptic deviceen_US
dc.subjectIntracranial pressureen_US
dc.subjectMonitoringen_US
dc.subjectBrain-tissue pressureen_US
dc.subjectHead-injured patientsen_US
dc.subjectClinical-evaluationen_US
dc.subjectInfectious complicationsen_US
dc.subjectAggressive treatmenten_US
dc.subjectExperienceen_US
dc.subjectDurationen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeContusionen_US
dc.subject.emtreeDevice infectionen_US
dc.subject.emtreeEpidural hematomaen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFiber opticsen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfection risken_US
dc.subject.emtreeIntracranial pressure monitoringen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMedical instrumentationen_US
dc.subject.emtreePatient safetyen_US
dc.subject.emtreePressure transduceren_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeTransduceren_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshChilden_US
dc.subject.meshChild, preschoolen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlasgow coma scaleen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshIntracranial hypertensionen_US
dc.subject.meshIntracranial pressureen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshMonitoring, physiologicen_US
dc.subject.meshOptical fibersen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshRetrospective studiesen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshStatistics, nonparametricen_US
dc.subject.meshYoung adulten_US
dc.subject.scopusVentriculostomy; Intracranial Pressure; Drainen_US
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.titleRisk factors and complications of intracranial pressure monitoring with a fiberoptic deviceen_US
dc.typeArticle
dc.wos.quartileQ4 (Neurosciences)en_US
dc.wos.quartileQ3 (Clinical neurology)en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
Scopus